Development of novel pyrazole, imidazo[1,2-b]pyrazole, and pyrazolo[1,5-a]pyrimidine derivatives as a new class of COX-2 inhibitors with immunomodulatory potential

This publication has 62 references indexed in Scilit:

• Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study
  Bioorganic & Medicinal Chemistry, 2011
• Synthesis and biological evaluation of some pyrazolylpyrazolines as anti-inflammatory–antimicrobial agents
  European Journal of Medicinal Chemistry, 2010
• Synthesis and biological evaluation of nitrogen-containing chalcones as possible anti-inflammatory and antioxidant agents
  Bioorganic & Medicinal Chemistry Letters, 2010
• QSAR analyses of conformationally restricted 1,5-diaryl pyrazoles as selective COX-2 inhibitors: application of connection table representation of ligands
  Bioorganic & Medicinal Chemistry Letters, 2005
• Highly Potent Inhibitors of TNF-α Production. Part 1: Discovery of Chemical Leads
  Bioorganic & Medicinal Chemistry Letters, 2002
• Expression and Proteolysis of Vascular Endothelial Growth Factor is Increased in Chronic Wounds
  Journal of Investigative Dermatology, 2000
• Anti-Cytokine Therapy for Rheumatoid Arthritis
  Annual Review of Medicine, 2000
• COX-2 inhibitors
  The Lancet, 1999
• ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
  Annual Review of Immunology, 1996
• Syntheses of 2-mercapto-4-substituted imidazole derivatives with antiinflammatory properties.
  Chemical and Pharmaceutical Bulletin, 1984